C

Cyclopharm Ltd
ASX:CYC

Watchlist Manager
Cyclopharm Ltd
ASX:CYC
Watchlist
Price: 1.46 AUD 8.15% Market Closed
Market Cap: 162.3m AUD
Have any thoughts about
Cyclopharm Ltd?
Write Note

Operating Margin
Cyclopharm Ltd

-30.2%
Current
-24%
Average
4.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-30.2%
=
Operating Profit
-8.8m
/
Revenue
29m

Operating Margin Across Competitors

Country AU
Market Cap 162.3m AUD
Operating Margin
-30%
Country US
Market Cap 205.2B USD
Operating Margin
17%
Country US
Market Cap 193.1B USD
Operating Margin
26%
Country US
Market Cap 148.6B USD
Operating Margin
22%
Country US
Market Cap 132.9B USD
Operating Margin
18%
Country IE
Market Cap 109.9B USD
Operating Margin
19%
Country US
Market Cap 64.8B USD
Operating Margin
14%
Country DE
Market Cap 56.6B EUR
Operating Margin
12%
Country CN
Market Cap 326.2B CNY
Operating Margin
36%
Country US
Market Cap 42.2B USD
Operating Margin
28%
Country US
Market Cap 37.7B USD
Operating Margin
13%
No Stocks Found

Cyclopharm Ltd
Glance View

Market Cap
162.3m AUD
Industry
Health Care

Cyclopharm Ltd. is a radiopharmaceutical company, which engages in the diagnostic imaging in lung health. The company provides diagnostic imaging services specializing in lung health. The firm through its medical device and pharmaceutical products under the name of Technegas, which has become the industry in diagnostic functional lung imaging technology. The company distributes its products in approximately 60 countries throughout the world with over 1500 nuclear medicine departments utilizing Technegas. The firm formed a joint venture with Alfred Health Solutions and Macquarie University Hospital to provide various imaging services on-site at the hospital. The Macquarie Medical Imaging (MMI) offers a range of diagnostic radiology, interventional radiology, nuclear medicine and molecular imaging services for inpatient and outpatients. Its Ultralute is a device that extends the useful life of Molybdenum-99 (Mo-99) generators.

CYC Intrinsic Value
2.05 AUD
Undervaluation 29%
Intrinsic Value
Price
C

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-30.2%
=
Operating Profit
-8.8m
/
Revenue
29m
What is the Operating Margin of Cyclopharm Ltd?

Based on Cyclopharm Ltd's most recent financial statements, the company has Operating Margin of -30.2%.